BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9336154)

  • 21. Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma.
    Al-Amro A; Al-Rajhi N; Khafaga Y; Memon M; Al-Hebshi A; El-Enbabi A; El-Husseiny G; Radawi A; Belal A; Allam A; El-Sebaie M
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):508-13. PubMed ID: 15890594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials.
    Cheng SH; Yen KL; Jian JJ; Tsai SY; Chu NM; Leu SY; Chan KY; Tan TD; Cheng JC; Hsieh CY; Huang AT
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):717-26. PubMed ID: 11395240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma.
    Lee AW; Tung SY; Chua DT; Ngan RK; Chappell R; Tung R; Siu L; Ng WT; Sze WK; Au GK; Law SC; O'Sullivan B; Yau TK; Leung TW; Au JS; Sze WM; Choi CW; Fung KK; Lau JT; Lau WH
    J Natl Cancer Inst; 2010 Aug; 102(15):1188-98. PubMed ID: 20634482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of locoregionally advanced nasopharyngeal carcinoma treated with intensity modulated irradiation and platinum-based chemotherapy.
    Xu JH; Guo WJ; Bian XH; Wu JF; Jiang XS; Guo YS; He X
    Cancer Radiother; 2013; 17(4):297-303. PubMed ID: 23849438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma.
    Ma J; Mai HQ; Hong MH; Min HQ; Mao ZD; Cui NJ; Lu TX; Mo HY
    J Clin Oncol; 2001 Mar; 19(5):1350-7. PubMed ID: 11230478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
    Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective study of the use of cisplatinum-5-fluorouracil neoadjuvant chemotherapy in cervical-node-positive nasopharyngeal carcinoma (NPC).
    Teo PM; Leung TW; Chan AT; Yu P; Lee WY; Leung SF; Kwan WH; Johnson P
    Eur J Cancer B Oral Oncol; 1995 Nov; 31B(6):373-9. PubMed ID: 8746267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma.
    Yan DF; Zhang WB; Ke SB; Zhao F; Yan SX; Wang QD; Teng LS
    BMC Cancer; 2017 Oct; 17(1):678. PubMed ID: 29020937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasopharyngeal carcinoma in children: retrospective review of 50 patients.
    Ayan I; Altun M
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):485-92. PubMed ID: 8655371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary tumor volume calculation as a predictive factor of prognosis in nasopharyngeal carcinoma.
    Lee CC; Chu ST; Ho HC; Lee CC; Hung SK
    Acta Otolaryngol; 2008 Jan; 128(1):93-7. PubMed ID: 17851945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of failure after induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma: the Queen Mary Hospital experience.
    Chua DT; Sham JS; Choy D; Kwong DL; Au GK; Kwong PW; Yau CC; Cheng AC; Wan KY
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1219-28. PubMed ID: 11286826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of primary gross tumor volume and standardized uptake value of
    Jin YN; Yao JJ; Wang SY; Zhang WJ; Zhou GQ; Zhang F; Cheng ZB; Ma J; Mo HY; Sun Y
    Tumour Biol; 2017 Jul; 39(7):1010428317717843. PubMed ID: 28671052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
    Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
    Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of primary tumor volume and T-stage on prognosis in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.
    Chen C; Fei Z; Pan J; Bai P; Chen L
    Jpn J Clin Oncol; 2011 Apr; 41(4):537-42. PubMed ID: 21242183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma.
    Hong RL; Ting LL; Ko JY; Hsu MM; Sheen TS; Lou PJ; Wang CC; Chung NN; Lui LT
    J Clin Oncol; 2001 Dec; 19(23):4305-13. PubMed ID: 11731513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant chemotherapy and radiation therapy compared with radiation therapy alone in advanced nasopharyngeal carcinoma.
    Hong S; Wu HG; Chie EK; Bang YJ; Heo DS; Kim KH; Sung MW; Park CI
    Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):901-5. PubMed ID: 10571196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced-Stage Nasopharyngeal Carcinoma: Restaging System after Neoadjuvant Chemotherapy on the Basis of MR Imaging Determines Survival.
    Liu LT; Chen QY; Tang LQ; Zhang L; Guo SS; Xie CM; Liu XW; Guo L; Mo HY; Chen MY; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Bei JX; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
    Radiology; 2017 Jan; 282(1):171-181. PubMed ID: 27479804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control.
    Sze WM; Lee AW; Yau TK; Yeung RM; Lau KY; Leung SK; Hung AW; Lee MC; Chappell R; Chan K
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):21-7. PubMed ID: 15093895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
    Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
    Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term survival of nasopharyngeal carcinoma patients treated with adjuvant chemotherapy subsequent to conventional radical radiotherapy.
    Prasad U; Wahid MI; Jalaludin MA; Abdullah BJ; Paramsothy M; Abdul-Kareem S
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):648-55. PubMed ID: 12062608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.